Your browser doesn't support javascript.
loading
Required dose of sugammadex or neostigmine for reversal of vecuronium-induced shallow residual neuromuscular block at a train-of-four ratio of 0.3.
He, Jing; He, Huan; Li, Xing; Sun, Mei; Lai, Zhihao; Xu, Bo.
Affiliation
  • He J; Department of Anesthesiology, General Hospital of Southern Theatre Command of PLA, Guangzhou, China.
  • He H; Department of Anesthesiology, General Hospital of Southern Theatre Command of PLA, Guangzhou, China.
  • Li X; Department of Anesthesiology, General Hospital of Southern Theatre Command of PLA, Guangzhou, China.
  • Sun M; Department of Anesthesiology, General Hospital of Southern Theatre Command of PLA, Guangzhou, China.
  • Lai Z; Department of Anesthesiology, General Hospital of Southern Theatre Command of PLA, Guangzhou, China.
  • Xu B; Department of Anesthesiology, General Hospital of Southern Theatre Command of PLA, Guangzhou, China.
Clin Transl Sci ; 15(1): 234-243, 2022 01.
Article in En | MEDLINE | ID: mdl-34435439
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vecuronium Bromide / Dose-Response Relationship, Drug / Delayed Emergence from Anesthesia / Sugammadex / Neostigmine Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Transl Sci Year: 2022 Document type: Article Affiliation country: China Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vecuronium Bromide / Dose-Response Relationship, Drug / Delayed Emergence from Anesthesia / Sugammadex / Neostigmine Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Transl Sci Year: 2022 Document type: Article Affiliation country: China Country of publication: Estados Unidos